Vazirani Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Vazirani Asset Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,000	Closed	-$527K	–	26
2026 Q1	$527K	Buy	+10,000	New	+$411K	1.22%	16

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vazirani Asset Management's TERN Position: Q2 2026 in Review

Vazirani Asset Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 10,000 shares — an estimated $527K sold.

Vazirani Asset Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $527K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Vazirani Asset Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Vazirani Asset Management sold 10,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $527K.
Vazirani Asset Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Vazirani Asset Management's Terns Pharmaceuticals position peaked at $527K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Vazirani Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.